CURELAB ONCOLOGY
Updated 36 days ago
CureLab Oncology is a biotechnology company that is developing new anti-cancer biologics...
Our lead product, Elenagen, is a plasmid (supercoiled circular DNA) encoding gene p62/SQSTM1. Elenagen reverses tumor grade, changes tumor microenvironment, enhances the anti-cancer effects of other therapies (e.g. chemotherapy), mitigates chronic inflammation, and stimulates an immune attack on the tumor.
Also known as: CureLab Oncology, Inc.